Brain changes and weight-loss medication for obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 18 years old or between 30 and 45 years old and have obesity (measured by body mass index).
- You can speak and understand English.
- You are willing and able to have an MRI (a safe brain scan that uses magnets).
- You have not taken a GLP-1 medication for weight loss in the last 3 months.
- You do not have type 2 diabetes, an eating disorder (anorexia or bulimia), or a serious neurological condition.
- If you are female, you are not currently pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests whether a weight loss medication called semaglutide can improve brain and blood vessel health in people with overweight or obesity. It may help you understand if this treatment could benefit your overall health.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
Hear when a new Obesity/Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.